Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 7/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.56 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | CTSV | O60911 | 3/20 | 0.56 |
| ▸ | CTSL | P07711 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.56 |
| ▸ | TUBB | P07437 | 1/20 | 0.56 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.56 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.56 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.56 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.56 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.56 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.56 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.56 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.56 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14084700 | 0.87 | HPGD (0.61) | HPGDKDM4ELMNACTSVCTSL | |
| SCHEMBL3928130 | 0.80 | HDAC11 (0.59) | HPGDCTSVCTSLRAB9ADAO | |
| SCHEMBL2791999 | 0.80 | CYP19A1 (0.59) | KDM4ELMNADAODDOCYP2C19 | |
| SCHEMBL27163686 | 0.80 | RAB9A (0.51) | HPGDKDM4ELMNACTSVCTSL | |
| SCHEMBL11556879 | 0.79 | HPGD (0.58) | HPGDKDM4ELMNACTSVCTSL | |
| SCHEMBL24035739 | 0.78 | ADORA2A (0.53) | HPGDKDM4ELMNAHSD17B10RAB9A | |
| SCHEMBL4880212 | 0.78 | HPGD (0.56) | HPGDKDM4ELMNACTSVCTSL | |
| SCHEMBL1354245 | 0.78 | PARP1 (0.63) | HPGDKDM4ELMNACTSVCTSL | |
| SCHEMBL7964360 | 0.78 | HPGD (0.56) | HPGDKDM4ELMNACTSVCTSL | |
| SCHEMBL28460210 | 0.78 | HPGD (0.56) | HPGDKDM4ELMNACTSVCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117886736-A | 2-indolyl-3-imine indoline derivative, preparation method and application thereof | 苏州昊帆生物股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-118221563-A | Synthesis method of 2-aryl indole | 南京工业大学 | 2024-06-21 | — | — | CN | disclosed |
| CN-117886736-A | 2-indolyl-3-imine indoline derivative, preparation method and application thereof | 苏州昊帆生物股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20080039625-A1 | Screening Methods | LAUTENS MARK | 2008-02-14 | — | — | US | disclosed |
| US-20080039625-A1 | Screening Methods | LAUTENS MARK | 2008-02-14 | — | — | US | disclosed |
| US-20080039625-A1 | Screening Methods | LAUTENS MARK | 2008-02-14 | — | — | US | disclosed |
| EP-1817283-A1 | 2-SUBSTITUTED INDOLES, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF | Lautens, Mark (CA) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006047888-A1 | 2-SUBSTITUTED INDOLES, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF | LAUTENS MARK (CA) | 2006-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039625-A1 | Screening Methods | CBR3, ZKSCAN2, CRBN | HPGD 4276/4885KDM4E 3829/4885LMNA 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.